A Boston-based startup is transforming shipping containers into high-tech hydroponic farms
Former first lady Nancy Reagan was a ‘true champion’ of Alzheimer’s disease.
Valeant Pharmaceuticals is under investigation by the SEC.
30 cancer patients are currently using wearable technology to ease cancer treatments.
A new report suggests that sleep apnea may have contributed to the death of Supreme Court Justice Antonin Scalia.
During an interview with the FOX Business Network’s Maria Bartiromo, California Republican lawmaker Darryl Issa provided detailed analysis of Hillary Clinton’s email probe.
No one likes to talk about it but it is a reality for many families.
The rising cost of prescription drugs are keeping baby boomers and seniors awake at night. What resources can older adults use when dealing with the rising costs?
The Zika virus is becoming more commonplace in the U.S. and experts say the South will feel the impact the most.
6Sensorslabs are creating portable food detectors for consumers to test foods for allergies
Incyte Corp said it would discontinue some of the trials testing its already approved blood cancer drug, Jakafi, after the treatment's effectiveness was found to be insufficient.
From tomatoes to sick employees, inside Chipotle’s nationwide store shut down
Fitness Mogul Shaun T talks fitness, building a business, and finding his ‘sanity’ in dance.
Women make up nearly half of the total workforce in the U.S. yet many women are earnings less than their male counterparts and struggling to save for retirement.
Former Turing Pharmaceuticals Chief Executive Officer Martin Shkreli invoked his Fifth Amendment right against self-incrimination and declined to answer questions from U.S. lawmakers.
AstraZeneca warned that revenue and earnings would drop this year due to the arrival of cheap generic rivals to its cholesterol fighter Crestor.
Merck posted declines in sales and profit as the pharmaceutical giant gave revenue projections below analyst forecasts and earnings expectations on the lower end of them.
Drugmaker Abbott Laboratories said it would acquire Alere for $5.8 billion to boost its global diagnostics presence.
Health insurer Aetna reported a 38 percent rise in quarterly profit, helped by strong performance in its government business that sells Medicare and Medicaid plans.
Theranos Inc.'s main retail partner is suspending some ties to the blood-testing laboratory in the wake of a critical regulatory inspection report.